SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
PROGRAMMATIC AND SCIENTIFIC ISSUES IN IMPLEMENTING HIV TREATMENT AND MONITORING
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
MORTALITY REDUCTION IN WESTERN KENYA DURING SCALE-UP OF HIV TREATMENT, 2011-2016 (ABSTRACT
146)
Emily C. Zielinski-Gutierrez
US Centers for Disease Control and Prevention, Nairobi, Kenya
OPIOID OVERDOSE DEATHS AMONG PERSONS WITH HIV INFECTION, UNITED STATES, 2011-2015 (ABSTRACT
147)
Karin A. Bosh
Centers for Disease Control and Prevention, Atlanta, GA, USA
EARLY MORTALITY IN HIV-INFECTED PATIENTS INITIATING ART WITHOUT A PRETHERAPY CD4 (ABSTRACT
148)
Kombatende Sikombe
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
UTILITY OF CD4 CELL COUNT MONITORING IN BOTSWANA: ANALYSIS OF ROUTINE LABORATORY DATA (ABSTRACT
149)
Tshepo Botho Leeme
Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana
TRENDS IN CD4 AND VIRAL LOAD TESTING IN SOUTHERN AFRICA: ANALYSIS OF 6 COUNTRIES (ABSTRACT
150)
Matthias Egger
University of Bern / Switzerland, Bern, Switzerland
HIGH LEVELS OF DRUG RESISTANCE AMONG ART-EXPERIENCED HOSPITALIZED PATIENTS (ABSTRACT
151)
Claire Bossard
Médecins Sans Frontières, Cape Town, South Africa
HIV DRUG RESISTANCE IN SOUTH AFRICA: RESULTS FROM A POPULATION-BASED HOUSEHOLD SURVEY (ABSTRACT
152)
Sizulu Moyo
Human Sciences Research Council, Cape Town, South Africa
DURATION OF INFECTIOUSNESS AMONG PERSONS WITH HIV DIAGNOSED DURING 2012-2016 (ABSTRACT
153)
Nicole Crepaz
Centers for Disease Control and Prevention, Atlanta, GA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
